XPAC Acquisition Corp. (XPAX) to Combine with SuperBac in $380M Deal

XPAC Acquisition Corp. (NASDAQ:XPAX) has entered into a definitive combination agreement with biotechnology firm SuperBac at a firm value of $380 million, or 1.5x its 2022E net revenue. Sao Paulo, Brazil-based SuperBac manufactures biological products from natural bacteria that aid in the agriculture, sanitation and oil and gas sectors. The combined company is expected to
Read More